-
1
CVD affects approximately 1 in 12 males and 1 in 200 females.
-
2
Bladder cancer presents with visible blood, often leading to earlier clinical evaluation.
-
3
Study utilized electronic health records for a retrospective cohort study.
-
4
Patients with CVD had lower survival rates in bladder cancer but not in colorectal cancer.
-
5
There is often a diagnostic gap concerning CVD in clinical practice.
-
6
The study highlights the impact of impaired recognition of visible blood on cancer detection.
Original Source(s)
Related Content
AI As Collaborator in Cancer Research and in Clinical Care
Last October, the Cancer AI Alliance (CAIA) announced the launch of its collaborative artificial intelligence (AI) platform powered by federated learning to train AI models with millions of de-identif...
by Jo Cavallo
March 30, 2026
-
10 min
Metabolic Subtypes of Nasopharyngeal Carcinoma and Response to Treatment
In a Chinese study reported in the Journal of Clinical Oncology, Huang et al developed a classification for metabolic subtypes of nasopharyngeal carcinoma that may help identify patients benefiting mo...
March 30, 2026
-
3 min
Diagnostics Explores the Fragmentome
An AI-augmented blood test detects early liver fibrosis and other diseases
March 30, 2026
-
5 min
